AccessPak for HIV PEP Expanded with Kaletra and Mirvaso topical
Determining the interaction of AccessPak for HIV PEP Expanded with Kaletra and Mirvaso topical and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: emtricitabine / lopinavir / ritonavir / tenofovir
Brand name: AccessPak for HIV PEP Expanded with Kaletra
Synonyms: n.a.
Generic Name: brimonidine topical
Brand name: Mirvaso, Mirvaso Pump
Synonyms: Mirvaso Gel, Mirvaso
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- AccessPak for HIV PEP Expanded with Kaletra-Misoprostol
- AccessPak for HIV PEP Expanded with Kaletra-Mitigare
- AccessPak for HIV PEP Expanded with Kaletra-Mitigo injection
- AccessPak for HIV PEP Expanded with Kaletra-Mitomycin
- AccessPak for HIV PEP Expanded with Kaletra-MitoMYcin (Systemic)
- AccessPak for HIV PEP Expanded with Kaletra-Mitomycin Intravenous
- Mirvaso topical-AccessPak for HIV PEP Expanded with Viracept
- Mirvaso topical-Accolate
- Mirvaso topical-Accretropin
- Mirvaso topical-Accucaine
- Mirvaso topical-AccuHist Drops
- Mirvaso topical-AccuHist PDX Drops